Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients

BACKGROUND: The oxaliplatin-based regimen FOLFOX is widely used to treat patients with advanced colorectal cancer (CRC). However, dose-limiting toxicity after continuous oxaliplatin administration can lead to peripheral neuropathy. Several agents, including opioids, that have been employed to treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nagashima, Makoto, Ooshiro, Mitsuru, Moriyama, Ayako, Sugishita, Yui, Kadoya, Kengo, Sato, Ayami, Kitahara, Tomoaki, Takagi, Ryuichi, Urita, Tasuku, Yoshida, Yutaka, Tanaka, Hiroshi, Oshiro, Takashi, Okazumi, Shinichi, Katoh, Ryoji
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4008774/
https://ncbi.nlm.nih.gov/pubmed/24452412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2132-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars